Updated with comments from Terumo. Cerus (NSDQ: CERS) and Terumo Corp. (TYO:4543) won grants from a U.S. Health & Human Services Dept. agency worth a collective $48 million to study their respective devices for eliminating blood pathogens like the Zika virus. Zika, which the World Health Organization declared a global emergency in February, has been linked to microcephaly, a birth […]
Zika virus
UPDATE: FDA allows emergency use of Hologic’s Aptima, Procleix test for the Zika virus
Hologic (NSDQ:HOLX) said it won an emergency use exemption from the FDA for its Aptima diagnostic to detect Zika virus and for it and Grifols (NSDQ:GRFS) Procleix Zika screening assay under the FDA’s Investigational New Drug protocol. The approval covers the detection of the Zika virus in human serum and plasma specimens and makes the test available immediately […]